IntroductionCancer and infections are leading causes of mortality in systemic lupus erythematosus (SLE) after diseases of the circulatory system, and therefore preventing these complications is important. In this study, we examined two categories of preventive services in SLE: cancer surveillance (cervical, breast, and colon) and immunizations (influenza and pneumococcal). We compared the receipt of these services in SLE to the general population, and identified subgroups of patients who were less likely to receive these services.MethodsWe compared preventive services reported by insured women with SLE enrolled in the University of California, San Francisco Lupus Outcomes Study (n=685) to two representative samples derived from a statewide ...
BACKGROUND:Systemic lupus erythematous (SLE) disproportionately impacts patients of color and socioe...
Objective: To assess cancer risk factors in incident systemic lupus erythematosus (SLE). Methods: Cl...
ObjectiveTo better understand why immunosuppressed individuals with systemic lupus erythematosus (SL...
IntroductionCancer and infections are leading causes of mortality in systemic lupus erythematosus (S...
ObjectiveIndividuals with systemic lupus erythematosus (SLE) are at high risk for infections and SLE...
Lupus nephritis (LN) is a major cause of among systemic lupus erythematosus (SLE) patients. Despite ...
Systemic lupus erythematosus (SLE or lupus) is an autoimmune multisystem disease. While a complete u...
Objective Infection is a leading cause of morbidity and mortality in systemic lupus erythematosus (S...
Objective: Concerns about the affordability of medications are common in systemic lupus erythematosu...
Background: Patients with systemic lupus erythematosus (SLE) have an increased risk of infections du...
ObjectiveInfection is a leading cause of morbidity and mortality in systemic lupus erythematosus (SL...
Infection is a leading cause of morbidity and mortality in systemic lupus erythematosus (SLE). Thera...
Background: Systemic lupus erythematosus (SLE) is a chronic disease characterised by autoimmunity an...
Objectives The survival rate of patients with systemic lupus erythematosus has improved in the last ...
OBJECTIVE: Treat-to-target end points for systemic lupus erythematosus (SLE) have been assessed for ...
BACKGROUND:Systemic lupus erythematous (SLE) disproportionately impacts patients of color and socioe...
Objective: To assess cancer risk factors in incident systemic lupus erythematosus (SLE). Methods: Cl...
ObjectiveTo better understand why immunosuppressed individuals with systemic lupus erythematosus (SL...
IntroductionCancer and infections are leading causes of mortality in systemic lupus erythematosus (S...
ObjectiveIndividuals with systemic lupus erythematosus (SLE) are at high risk for infections and SLE...
Lupus nephritis (LN) is a major cause of among systemic lupus erythematosus (SLE) patients. Despite ...
Systemic lupus erythematosus (SLE or lupus) is an autoimmune multisystem disease. While a complete u...
Objective Infection is a leading cause of morbidity and mortality in systemic lupus erythematosus (S...
Objective: Concerns about the affordability of medications are common in systemic lupus erythematosu...
Background: Patients with systemic lupus erythematosus (SLE) have an increased risk of infections du...
ObjectiveInfection is a leading cause of morbidity and mortality in systemic lupus erythematosus (SL...
Infection is a leading cause of morbidity and mortality in systemic lupus erythematosus (SLE). Thera...
Background: Systemic lupus erythematosus (SLE) is a chronic disease characterised by autoimmunity an...
Objectives The survival rate of patients with systemic lupus erythematosus has improved in the last ...
OBJECTIVE: Treat-to-target end points for systemic lupus erythematosus (SLE) have been assessed for ...
BACKGROUND:Systemic lupus erythematous (SLE) disproportionately impacts patients of color and socioe...
Objective: To assess cancer risk factors in incident systemic lupus erythematosus (SLE). Methods: Cl...
ObjectiveTo better understand why immunosuppressed individuals with systemic lupus erythematosus (SL...